Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Satsuma Pharmaceuticals, Inc. (STSA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/19/2021 |
3
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 10/12/2021 |
3
| Harsch Mutya (Director) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 07/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/12/2019 |
3
| Hadley Harbor Master Investors (Cayman) II L.P. (10% Owner) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| RA CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| TAKANASHI KEN (10% Owner) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| Riebe Michael T (Director) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| Shah Rajeev M. (10% Owner) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| ALBRECHT DETLEF (Chief Medical Officer) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| Kollins John A (President and CEO) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| Sandoval Elisabeth (Director) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| Lukatch Heath (Director) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| KING THOMAS BRAXTON (Director) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
| 09/12/2019 |
3
| O'Neil Thomas P. (CFO) has filed a Form 3 on Satsuma Pharmaceuticals, Inc. |
|
|